Treatment of acute aortic insufficiency with sodium nitroferricyanide. Documentation of beneficial effect by noninvasive means.
The findings in a patient with acute aortic insufficiency who was treated with sodium nitroferricyanide (sodium nitroprusside) prior to aortic valve replacement are presented. Administration of the drug resulted in clinical improvement, which was reflected in changes in systemic and pulmonary arterial pressures and in noninvasive measurements. Sodium nitroferricyanide is useful in the management of patients with severe acute aortic insufficiency, and its effect may be monitored by noninvasive means.
D001022:Aortic Valve Insufficiency / Q000188:drug therapy*; D004077:Digoxin / Q000627:therapeutic use; D005292:Ferricyanides / Q000627:therapeutic use*; D005665:Furosemide / Q000627:therapeutic use; D006326:Heart Auscultation; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009599:Nitroprusside / Q000627:therapeutic use*
D005292:Ferricyanides; D009599:Nitroprusside; D004077:Digoxin; D005665:Furosemide